Literature DB >> 4066689

Origin of apolipoprotein A-I polymorphism in plasma.

G Ghiselli, M F Rohde, S Tanenbaum, S Krishnan, A M Gotto.   

Abstract

The origin and the functional significance of apo-A-I polymorphism in man has been investigated. Together with proapo-A-I (identified as A-I1 of the polymorphic series), four other isoforms are found in human plasma, namely A-I2, A-I3, A-I4, and A-I5. A-I3 is the "mature" product of proapo-A-I conversion in plasma. In this study we provide evidence that the other, more acidic, mature apo-A-I isoproteins are derived from A-I3 by a stepwise deamidation process. This conclusion is based on the following observations. 1) Incubation of A-I3 or A-I4, either free or associated with high density lipoprotein, produces a series of more acidic isoproteins corresponding to the sequence found in plasma. The conversion process fits in well with a first order reaction, and A-I3 to A-I4 conversion occurs virtually at the same rate as A-I4 to A-I5 conversion. 2) A-I3 and A-I4 have the same NH2- and C-terminal residues. 3) Formation of apo-A-I acidic isoproteins is accompanied by liberation of ammonia. In order to investigate whether deamidation of apo-A-I results in the production of forms which have different catabolism, a series of turnover studies was carried out in normal volunteers. A-I3 and A-I4 residence times in plasma were, respectively, 3.50 +/- 0.16 and 3.00 +/- 0.10 days (mean +/- S.E.; n = 3). Degradation rate of A-I3 was 8.81 +/- 0.69 mg/kg/day and that of A-I4 was 1.66 +/- 0.15 mg/kg/day (mean +/- S.E.; n = 3). Conversion of A-I3 to A-I4 and A-I4 to A-I5 occurred at the same rate in vivo as that observed in vitro. These results are consistent with the concept that A-I3 is the precursor to the other mature apo-A-I isoforms in plasma. A-I3 is the major isoform through which apo-A-I is eliminated from plasma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4066689

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Macrophage metalloproteinases degrade high-density-lipoprotein-associated apolipoprotein A-I at both the N- and C-termini.

Authors:  Ivano Eberini; Laura Calabresi; Robin Wait; Gabriella Tedeschi; Angela Pirillo; Lina Puglisi; Cesare R Sirtori; Elisabetta Gianazza
Journal:  Biochem J       Date:  2002-03-15       Impact factor: 3.857

2.  10th International Conference on Methods in Protein Structure Analysis. September 8-13, 1994, Snowbird, Utah. Short communications and abstracts.

Authors: 
Journal:  J Protein Chem       Date:  1994-07

3.  Increased proportion of proapolipoprotein A-I in HDL from patients with liver cirrhosis and hepatitis.

Authors:  T Matsuura; S Koga; H Ibayashi
Journal:  Gastroenterol Jpn       Date:  1988-08

4.  Identification of de novo synthesized and relatively older proteins: accelerated oxidative damage to de novo synthesized apolipoprotein A-1 in type 1 diabetes.

Authors:  Abdul Jaleel; Gregory C Henderson; Benjamin J Madden; Katherine A Klaus; Dawn M Morse; Srinivas Gopala; K Sreekumaran Nair
Journal:  Diabetes       Date:  2010-07-09       Impact factor: 9.461

5.  Identification of sites in apolipoprotein A-I susceptible to chymase and carboxypeptidase A digestion.

Authors:  Yoko Usami; Yukihiro Kobayashi; Takahiro Kameda; Akari Miyazaki; Kazuyuki Matsuda; Mitsutoshi Sugano; Kenji Kawasaki; Yuriko Kurihara; Takeshi Kasama; Minoru Tozuka
Journal:  Biosci Rep       Date:  2012-12-06       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.